RXRX
NASDAQ · Biotechnology
Recursion Pharmaceuticals-A
$3.52
+0.02 (+0.57%)
Next Earnings Report
Earnings History
| Date | Quarter | EPS Est | EPS Actual | Surprise | Surprise % | Result |
|---|---|---|---|---|---|---|
| Aug 11, 2026 | Q3 FY2026 | $-0.24 | — | — | — | — |
| May 11, 2026 | Q2 FY2026 | $-0.28 | — | — | — | — |
| Feb 25, 2026 | Q1 FY2026 | $-0.32 | — | — | — | — |
Related Earnings News
AbCellera Shares Jump 9.7% Ahead of Key Phase 2 Data Release
Recursion Pharmaceuticals Rallies as Short Interest and Russell Flows Drive AI-Biotech Surge
Recursion Pharma Rallies Past Biotech ETFs; Insider Sales and Cash Position in Focus
Recursion Pharmaceuticals Surges on Heavy Volume, Short Interest in Focus